Soluble Therapeutics Acquired by CytoBioscience more

Young Living Essential Oils Partners with TFS Sandalwood Farms more

Beaufort Memorial Using Xenex Germ-Zapping Robot to Destroy Pathogens That Can Cause Hospital-Acquired Infections more

DNAtrix to Present Clinical Data at the 21st Annual Meeting of the Society for Neuro-Oncology more

Cartersville Medical Center Unveils Xenex Germ-Zapping Robot more

DNAtrix enters into license agreement with University of Florida to develop new oncolytic virus platform more

DNAtrix Licenses Myxoma Virus for New Immunotherapy Platform more

Supportive Data for the Use of Santalis Pharmaceuticals’ East Indian Sandalwood Oil (EISO) for the Treatment of Psoriasis is Presented at International Conference more

Santalis Pharmaceuticals Obtains FDA Allowance To Start A Phase 2 Clinical Study For The Treatment Of Mild To Moderate Atopic Dermatitis (AD) more

DNAtrix Announces First Patients Treated in Phase 2 Trial with DNX-2401 and KEYTRUDA more

Robotics: Germ-Zappers Are Saving Lives more

DHR first in RGV with xenon UV disinfection systems more

neoSurgical® Announces CE Mark Approval of the neoClose® Laparoscopic Port Closure Device more

Germ-zapping robot named 'Gronk' helped kill MRSA at Mass. high school more

Doctors Hospital at Renaissance is First in Rio Grande Valley to Deploy Xenex Germ-Zapping Robots more

Bio2 Medical's Angel Catheter successfully placed in first two patients more

Cardiovate Develops First Bioabsorbable Vascular Graft more

Funding San Antonio’s Biotech Ecosystem more

A biotech groups to share in major military contract to manufacture stem cells more

Robot disinfecting rooms at Life Line Hospital in Wintersville more

Life Line Hospital is the First Long Term Acute Care Hospital in Ohio to Enhance Patient Safety by Deploying a Xenex Germ-Zapping Robot more

Robots show Marin, Sonoma hospitals the light on disinfection more

Santalis Pharmaceuticals Announces Issuance of Patent for the Use of Sandalwood Oil to Treat Cancers more

Santalis Pharmaceuticals Initiates a Phase 2 Study of Mild, Moderate and Severe Atopic Dermatitis - Enrolls First Patient Into Its Australian Clinical Trial Site more

With Scaffold for Regenerating Arteries, Cardiovate Raises $350,000 more

Bluegrass Vascular Secures CE Mark Approval and Announces Successful Commercial Use of The Surfacer® Inside-Out® Access Catheter System more

Bio2 Medical® Closes on $3 Million of Venture Debt Financing more

Tropical Forestry Services prepares for first Indian sandalwood shipment to China more

Bio2 Medical® Announces 510(k) Clearance from the FDA for the Angel® Catheter, the First Ever Prophylactic Use Indication for a Medical Device for Pulmonary Embolism more

International perfumery competition winner tours Indian sandalwood plantations in the Kimberley more

SA biotech firm drawing global interest year after moving from Germany more

TFS Corporation makes bond offer more

New robot system at USC Verdugo Hills Hospital uses UV light to disinfect hospital rooms more

DNAtrix wins $2 million FDA grant for cancer immunotherapy more

DNAtrix Awarded FDA Orphan Products Development Grant for DNX-2401 more

TFS Corporation - July 2016 Update more

StemBioSys reaches European distribution agreement for its products more

BRIEF-Diamyd Medical: Cellaviva appointed European distributor for StemBioSys more

DNAtrix Receives European Medicines Agency PRIME Designation more

DNAtrix Announces Successful Intratumoral Delivery of DNX-2401 via Alcyone's MEMS Cannula for the Targeted Treatment of Recurrent Glioblastoma more

Australia forestry company TFS Corp gets two ratings upgrades more

Tour of Texas: Valence, Stellarray, Flux Farms, A&M, StemBioSys more

StemBioSys reaches distribution agreement for its products in South Korea more

Camden Clark Medical Center Introduces Newest Xenex Germ-Zapping Robot more

MPR Client Innovative Trauma Care Wins Gold at 2016 Medical Design Excellence Awards more

Santalis Pharmaceuticals Announces Positive Results From a Study Using 10% East Indian Sandalwood Oil (EISO) Serum Formulation for the Treatment of Mild-to-Moderate Plaque Psoriasis more

Texas among top states in foreign investments more

How Your Family Drives Business Decisions more

StemBioSys enters distribution agreement for its products in Japan more

San Antonio biotech firm takes big step toward global expansion more

Vidant Edgecombe Hospital adds Xenex Germ-Zapping Robot to reduce HAIs more

This hospital spent $300,000 on giant, superbug-killing robots more

Santalis Announces First Subject Enrolled in Phase 2 Trial of East Indian Sandalwood Oil (EISO) to Treat Mild to Moderate Plaque Psoriasis more

SA biotech company backing fed stem cell bill to cut red tape from regulatory pathway more

Bexar County added 4,350 jobs last year, study says more

Springfield Clinic unveils Xenex Germ-Zapping Robot for infection control more

San Antonio venture capital funding fell last year more

neoSurgical Limited Expands Indications For neoClose Device more

Bio2 Medical Closes Series D Preferred Stock more

TFS undertakes $60 million placement more

Bluegrass Vascular Technologies’ catheter system used on first patient more

Cytocentrics refunds $100,000 in economic development funds to city more

Bluegrass Vascular Technologies Announces First Clinical Use of the Surfacer® Inside-Out® Access Catheter System in Europe. more

Long-term acute care facility in California implements Xenex germ-zapping robot more

Robotic housekeeper disinfects the rooms at Modesto hospital more

Aerin Medical raises $16.7M, adds new board members more

Brokers Sniff Sweet Potential In TFS Corp more

East Indian sandalwood oil (EISO) is the key ingredient in these grooming products for dogs more

Santalis Pharmaceuticals Completes the Spin-Off of Roxy’s Remedies Inc. more

TFS Corporation - January 2016 Update more

DNAtrix's Oncolytic Immunotherapy, DNX-2401, Awarded EU Orphan Medicine Designation more

Strategic partnering deal with Cytocentrics more

Cytocentrics CEO: San Antonio to get big boost from new deal more

GhostBuster the Lab Mix Reviews Roxy’s Remedies Pure Relief Spray Gel more

Avera McKennan Addresses Patient Safety with Germ-Zapping Robots; First Hospital in South Dakota to Deploy Xenex to Eliminate Pathogens that Cause Infections

SIOUX FALLS, S.D.--(BUSINESS WIRE)--Feb 22, 2016--Meet Xena the germ-zapping warrior. She's one of two new robots at Avera McKennan Hospital & University Health Center that are super cleaners, able to destroy hard-to-kill superbugs — including those that cause hospital-acquired infections — within minutes by sending out intense pulses of ultraviolet (UV) light.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20160222006471/en/

Meet Xena -- the first Germ-Zapping Robot in South Dakota. Avera McKennan Hospital is the first healthcare facility in South Dakota, to utilize Xenex Germ-Zapping Robots to destroy the germs and bacteria that can lurk on surfaces and cause infections. (Photo: Business Wire)

The Xenex pulsed xenon UV robots will be used to disinfect critical areas at Avera McKennan. The goal is to have cleaner surfaces and areas, in order to help prevent hospital-acquired infections, which are often associated with complications and in some cases, death.

"This is all about improving patient safety. In other hospitals, pulsed xenon UV robots have reduced hospital-acquired infection rates significantly — in some studies by more than 50 percent. That's a game changer for both patients and staff," said Mary Leedom, Assistant Vice President of Surgical Services at Avera McKennan. "Although our infection rates are very low, we all know that hospital acquired infections can occur anywhere. We wanted to ensure that we are using the most cutting-edge technology to create an even safer environment for patients."

The two robots will be used to disinfect operating rooms, the Ambulatory Surgery Center,   the Intensive Care Unit (ICU) and the Oncology Transplant Unit at Avera McKennan. The UV disinfection system will add another layer of protection to the hospital's standard disinfection process. Research shows that manual cleaning alone may remove less than half of the pathogens. Xenex robots have been shown in multiple peer-reviewed published studies to significantly reduce the amount of pathogens in hospital rooms.

After a standard room cleaning, the robot is brought in to the empty room and pulses intense UV-C light that kills bacteria, funguses and viruses within minutes. The light disinfects hard-to-reach places that humans might miss during the manual cleaning process.
Hospitals across the country have been adding Xenex pulsed xenon UV light disinfection systems to their infection prevention programs as clinical evidence has shown the benefits of broad spectrum UV light.

Clinical research shows the pulsed xenon UV room disinfection system quickly destroys even the most dangerous pathogens.   For example, hospitals using pulsed xenon UV have published peer-reviewed studies demonstrating a 100 percent decrease in Surgical Site Infection (SSI) rates, a 53 percent reduction in infection rates for Clostridium difficile (C.diff ), which can be resistant to general disinfection, and a 57 percent reduction in Methicillin-resistant Staphylococcus aureus (MRSA) infection rates, a bacteria that is fairly easy to kill but not as easy to treat.

Avera McKennan, the first hospital in South Dakota to implement Xenex Germ-Zapping Robots™, is participating in a clinical research study with Xenex, the robot manufacturer. The study will look at orthopedic infection rates at Avera and compare the rates to the previous 12 months to measure the decrease in infection rates. Avera also tracks infection rates as part of performance improvement.
"Once we see how well these perform, our goal is to acquire more units. We want to provide the same standard of care for all our patients," said Judy Lamphron, Infection Control Program Manager at Avera McKennan.

What is it?
The square-shaped robots are about 4 feet tall, easily portable, and produce high-intensity UV light by pulsing xenon, an inert gas, in an ultraviolet flash lamp. The UV light passes through the cell walls of bacteria, viruses and bacterial spores and eliminates them without any contact or chemicals in a five-minute disinfection cycle.

Source: https://www.ksl.com back

Santalis Pharmaceuticals Announces Positive Results from a Study of Pediatric Patients with Eczema more

Santalis announces positive results for pediatric atopic dermatitis treatment more

Here’s why the TFS Corporation Limited share price soared 28% today more

Cytocentrics gaining traction in San Antonio more

The Drugstore Acne Fighters Dermatologists Swear By more

neoSurgical® Begins Postmarket Surveillance Study more

Santalis Announces First Subject Enrolled in Phase 2 Trial more

BiO2 Medical Reports Positive Advancement of the Series D Round of Funding more

Germany’s Axiogenesis to collaborate with new San Antonio biotech company more